凝血因子Ⅴ(F5)重組蛋白
Recombinant Coagulation Factor V (F5)
FV; FVL; PCCF; Proaccelerin; Labile Factor; Factor V Leiden; Accelerator Globulin; Activated protein C cofactor; Proaccelerin, labile factor
- 編號RPA675Hu03
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位分泌
- 預測分子量35.2kDa
- 實際分子量34kDa(差異分析請參閱說明書)
- 片段與標簽Arg1908~Val2203 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點9.5
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1114 ¥ 2784 ¥ 5568 ¥ 16704 ¥ 41760
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。
增值服務
相關產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
RPA675Hu01 | 凝血因子Ⅴ(F5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA675Hu02 | 凝血因子Ⅴ(F5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA675Hu03 | 凝血因子Ⅴ(F5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA675Hu01 | 凝血因子Ⅴ(F5)多克隆抗體 | WB,IHC,ICC/IF |
PAA675Hu03 | 凝血因子Ⅴ(F5)多克隆抗體 | WB; IHC; ICC; IP. |
PAA675Hu02 | 凝血因子Ⅴ(F5)多克隆抗體 | WB; IHC; ICC; IP. |
LAA675Hu81 | 凝血因子Ⅴ(F5)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
LAA675Hu71 | 凝血因子Ⅴ(F5)多克隆抗體(生物素標記) | WB; IHC; ICC. |
MAA675Hu22 | 凝血因子Ⅴ(F5)單克隆抗體 | WB; IHC; ICC; IP. |
SEA675Hu | 凝血因子Ⅴ(F5)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA675Hu | 凝血因子Ⅴ(F5)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
Biochem Biophys Res Commun | Thrombin generation in abdominal sepsis is Rho-kinase-dependent [PubMed: 25813486] |
Cell Transplantation | Evidence of a Pivotal Role for the Distal Part of the Complement Cascade in the Diurnal Release of Hematopoietic Stem Cells Into Peripheral Blood [Pubmed:26087465] |
Cardiovascular?Research | Loss of accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activity [Pubmed:29444200] |
留言咨詢